Cargando…
Last Resort Antibiotics Costs and Reimbursement Analysis of Real-Life ICU Patients with Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Germany
Multidrug-resistant Gram-negative bacteria (MDR-GNB) cause serious infections and aggravate disease progression. Last resort antibiotics are effective against MDR-GNB and are reimbursed by flat rates based on German diagnosis-related groups (G-DRG). From a hospital management perspective, this analy...
Autores principales: | Jeck, Julia, Wingen-Heimann, Sebastian M., Jakobs, Florian, Franz, Jennifer, Baltin, Christoph T., Kron, Anna, Böll, Boris, Kochanek, Matthias, Cornely, Oliver A., Kron, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778355/ https://www.ncbi.nlm.nih.gov/pubmed/36554068 http://dx.doi.org/10.3390/healthcare10122546 |
Ejemplares similares
-
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany
por: Jakobs, Florian, et al.
Publicado: (2021) -
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital
por: Jeck, Julia, et al.
Publicado: (2021) -
Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier
por: Jakobs, Florian, et al.
Publicado: (2022) -
Health-economic modelling of cost savings due to the use of rezafungin based on a German cost-of-illness study of candidiasis
por: Jeck, Julia, et al.
Publicado: (2023) -
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center
por: Bonn, Jennifer, et al.
Publicado: (2023)